Helmut R Salih (Helmut Salih)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

Cancers

Science translational medicine

International journal of molecular sciences

Nature communications

German Cancer Consortium, German Cancer Research Center and University of Tuebingen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

German Cancer Consortium, German Cancer Research Center and University of Tuebingen

Germany

Head and Medical Director :: Clinical collaboration unit translational immunology

Publications

Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Polina Kaidun, Samuel J Holzmayer, Sarah M Greiner, Anna Seller, Christian Martin Tegeler, Ilona Hagelstein, Jonas Mauermann, Tobias Engler, André Koch, Andreas Daniel Hartkopf, Helmut R Salih, Melanie Märklin
Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer. International journal of molecular sciences 24 (17) (2023)
Annika Nelde, Heiko Schuster, Jonas S Heitmann, Jens Bauer, Yacine Maringer, Melissa Zwick, Jens-Peter Volkmer, James Y Chen, Anna M Paczulla Stanger, Ariane Lehmann, Bismark Appiah, Melanie Märklin, Elke Rücker-Braun, Helmut R Salih, Malte Roerden, Sarah M Schroeder, Max-Felix Häring, Andreas Schlosser, Johannes Schetelig, Marc Schmitz, Melanie Börries, Natalie Stickel, Claudia Lengerke, Ravindra Majeti, Irving L Weissman, Hans-Georg Rammensee, Juliane Sarah Walz
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood cancer discovery (2023)
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M Rittig, Christian M Tegeler, Yacine Maringer, Simon U Jaeger, Monika Denk, Marion Richter, Melek T Oezbek, Karl-Heinz Wiesmüller, Jens Bauer, Jonas Rieth, Marcel Wacker, Sarah M Schroeder, Naomi Hoenisch Gravel, Jonas Scheid, Melanie Märklin, Annika Henrich, Boris Klimovich, Kim L Clar, Martina Lutz, Samuel Holzmayer, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W Löffler, Caroline Anna Peuker, Stefan Habringer, Thorsten O Goetze, Elke Jäger, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nature communications 14 (1) (2023)
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, Lena Mühlenbruch, Sarah M Schroeder, Marian C Neidert, Jonas Scheid, Steffen Lemke, Marissa L Dubbelaar, Marcel Wacker, Anna Dengler, Reinhild Klein, Paul-Stefan Mauz, Hubert Löwenheim, Mathias Hauri-Hohl, Roland Martin, Jörg Hennenlotter, Arnulf Stenzl, Jonas S Heitmann, Helmut R Salih, Hans-Georg Rammensee, Juliane Sarah Walz
TOF IMS mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nature communications 14 (1) (2023)
Joseph Kauer, Melanie Märklin, Martin Pflügler, Sebastian Hörner, Clemens Hinterleitner, Claudia Tandler, Gundram Jung, Helmut R Salih, Jonas S Heitmann
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro. Journal of cancer research and clinical oncology 148 (10) (2022)
Jens Bauer, Natalie Stickel, Yacine Maringer, Philip Bucher, Tatjana Bilich, Melissa Zwick, Severin Dicks, Annika Nelde, Marissa L Dubbelaar, Jonas Scheid, Marcel Wacker, Jonas S Heitmann, Sarah Schroeder, Jonas Rieth, Monika Denk, Marion Richter, Reinhild Klein, Irina Bonzheim, Julia Luibrand, Ursula Holzer, Martin Ebinger, Ines B Brecht, Michael Bitzer, Melanie Boerries, Judith Feucht, Helmut R Salih, Hans-Georg Rammensee, Stephan Hailfinger, Juliane Sarah Walz
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Nature communications 13 (1) (2022)
Christian Martin Tegeler, Jonas Scheid, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz, Jonas S Heitmann, Annika Nelde
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients. Cancers 14 (9) (2022)
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut R Salih, Michael Lübbert, Michael W M Kühn, Thomas Schroeder, Hans Salwender, Katharina S Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard A Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications. Blood advances 6 (18) (2022)
Elisa Donato, Nadia C Correia, Carolin Andresen, Darja Karpova, Roberto Würth, Corinna Klein, Markus Sohn, Adriana Przybylla, Petra Zeisberger, Kathrin Rothfelder, Helmut R Salih, Halvard Bonig, Sebastian Stasik, Christoph Röllig, Anna Dolnik, Lars Bullinger, Frank Buchholz, Christian Thiede, Daniel Hübschmann, Andreas Trumpp
Retained functional normal and preleukemic HSCs at diagnosis are associated to good prognosis in DNMT3Amut NPM1mut AMLs. Blood advances (2022)
Sebastian Hörner, Moustafa Moustafa-Oglou, Karin Teppert, Ilona Hagelstein, Joseph Kauer, Martin Pflügler, Kristina Neumann, Hans-Georg Rammensee, Thomas M Metz, Andreas Herrmann, Helmut R Salih, Gundram Jung, Latifa Zekri
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases. Cancers 14 (16) (2022)
Laura K Schmalbrock, Anna Dolnik, Sibylle Cocciardi, Eric Sträng, Frauke Theis, Nikolaus Jahn, Ekaterina Panina, Tamara J Blätte, Julia Herzig, Sabrina Skambraks, Frank G Rücker, Verena I Gaidzik, Peter Paschka, Walter Fiedler, Helmut R Salih, Gerald Wulf, Thomas Schroeder, Michael Lübbert, Richard F Schlenk, Felicitas Thol, Michael Heuser, Richard A Larson, Arnold Ganser, Hendrik G Stunnenberg, Saverio Minucci, Richard M Stone, Clara D Bloomfield, Hartmut Döhner, Konstanze Döhner, Lars Bullinger
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin. Blood 137 (22) (2021)
Joseph Kauer, Fabian Vogt, Ilona Hagelstein, Sebastian Hörner, Melanie Märklin, Stefanie Maurer, Helmut R Salih, Gundram Jung, Latifa Zekri
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies. Cancers 13 (18) (2021)
Fabian Riegg, Martina S Lutz, Bastian J Schmied, Jonas S Heitmann, Manon Queudeville, Peter Lang, Gundram Jung, Helmut R Salih, Melanie Märklin
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers 13 (7) (2021)
Tatjana Bilich, Annika Nelde, Jonas S Heitmann, Yacine Maringer, Malte Roerden, Jens Bauer, Jonas Rieth, Marcel Wacker, Andreas Peter, Sebastian Hörber, David Rachfalski, Melanie Märklin, Stefan Stevanovic, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Science translational medicine 13 (590) (2021)
Kübra Kaban, Clemens Hinterleitner, Yanjun Zhou, Emine Salva, Ayse Gülten Kantarci, Helmut R Salih, Melanie Märklin
Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer. Cancers 13 (10) (2021)
Kim L Clar, Lisa Marie Weber, Bastian J Schmied, Jonas S Heitmann, Maddalena Marconato, Claudia Tandler, Pascal Schneider, Helmut R Salih
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course. Cancers 13 (23) (2021)
Yanjun Zhou, Jonas S Heitmann, Kim L Clar, Korbinian N Kropp, Clemens Hinterleitner, Tobias Engler, André Koch, Andreas D Hartkopf, Lars Zender, Helmut R Salih, Stefanie Maurer, Clemens Hinterleitner
Platelet-expressed immune checkpoint regulator GITRL in breast cancer. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Kübra Kaban, Sarah M Greiner, Samuel Holzmayer, Claudia Tandler, Sophie Meyer, Clemens Hinterleitner, Helmut R Salih, Melanie Märklin, Jonas S Heitmann
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL). Diagnostics (Basel, Switzerland) 11 (11) (2021)
Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, Martina Hinterleitner, André Koch, Andreas D Hartkopf, Helmut R Salih, Clemens Hinterleitner, Stefanie Maurer
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer? Diagnostics (Basel, Switzerland) 11 (7) (2021)
Jonas S Heitmann, Tatjana Bilich, Claudia Tandler, Annika Nelde, Yacine Maringer, Maddalena Marconato, Julia Reusch, Simon Jäger, Monika Denk, Marion Richter, Leonard Anton, Lisa Marie Weber, Malte Roerden, Jens Bauer, Jonas Rieth, Marcel Wacker, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W Löffler, Julia Karbach, Elke Jäger, Reinhild Klein, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature (2021)
Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth, Marcel Wacker, Fiamma Berner, Lukas Flatz, Stefanie Held, Peter Brossart, Melanie Märklin, Philipp Wagner, Eva Erne, Reinhild Klein, Hans-Georg Rammensee, Helmut R Salih, Juliane S Walz
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer. Cancer discovery 11 (8) (2021)
Jonas S Heitmann, Martin Pfluegler, Gundram Jung, Helmut R Salih
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives. Cancers 13 (3) (2021)
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, Lukas Osburg, Helmut R Salih, Joseph Kauer, Melanie Märklin
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML. Leukemia & lymphoma 61 (10) (2020)
Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer. EMBO molecular medicine 13 (2) (2020)
Claudia Tandler, Moritz Schmidt, Jonas S Heitmann, Julia Hierold, Jonas Schmidt, Pascal Schneider, Daniela Dörfel, Juliane Walz, Helmut R Salih
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia. Cancers 12 (10) (2020)
Helmut R Salih, Gundram Jung
The challenges of translation. EMBO molecular medicine 11 (12) (2019)

Helmut R Salih.css-eqlu8i{font-size:small;padding-left:4px;} (Helmut Salih)

Publication Activity (10 Years)

Top Topics

Top Venues

Helmut R Salih (Helmut Salih)